Explore more publications!
Djibouti Health Journal
Submit Press Release

Djibouti Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Djibouti Health Journal.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on September 3, 2025

Molecular Assay Market to Grow at a CAGR of 7% During the Forecast Period (2025 – 2030): Wissen Research
September 3, 2025

Molecular Assay Market to Grow at a CAGR of 7% During the Forecast Period (2025 – 2030): Wissen Research

Indeterminate GlobeNewswire
Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365
September 3, 2025

Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365

Indeterminate GlobeNewswire
UPDATE -- vTv Therapeutics to Participate in Upcoming September Investor Conferences
September 3, 2025

UPDATE -- vTv Therapeutics to Participate in Upcoming September Investor Conferences

Indeterminate GlobeNewswire
Sotera Health Announces Secondary Offering of Common Stock
September 3, 2025

Sotera Health Announces Secondary Offering of Common Stock

Indeterminate GlobeNewswire
Artelo Biosciences Announces Proposed Underwritten Public Offering
September 3, 2025

Artelo Biosciences Announces Proposed Underwritten Public Offering

Indeterminate GlobeNewswire
DBV Technologies to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
September 3, 2025

DBV Technologies to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Indeterminate GlobeNewswire
DBV Technologies participera à la 27e conférence annuelle H.C. Wainwright Global Investment
September 3, 2025

DBV Technologies participera à la 27e conférence annuelle H.C. Wainwright Global Investment

Indeterminate GlobeNewswire
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 3, 2025

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Pennant Announces Home Health Acquisition in Wyoming
September 3, 2025

Pennant Announces Home Health Acquisition in Wyoming

Indeterminate GlobeNewswire
New Meta-Analysis Demonstrates that Access to the GeneSight Test Can Significantly Improve Response and Remission Rates for Patients with Depression
September 3, 2025

New Meta-Analysis Demonstrates that Access to the GeneSight Test Can Significantly Improve Response and Remission Rates for Patients with Depression

Indeterminate GlobeNewswire
Avadel Pharmaceuticals Strengthens Sleep Medicine Portfolio with Exclusive License of Valiloxybate from XWPharma Ltd
September 3, 2025

Avadel Pharmaceuticals Strengthens Sleep Medicine Portfolio with Exclusive License of Valiloxybate from XWPharma Ltd

Indeterminate GlobeNewswire
Surrozen to Present at Upcoming Healthcare Investor Conference
September 3, 2025

Surrozen to Present at Upcoming Healthcare Investor Conference

Indeterminate GlobeNewswire
Tevogen Underscores the Importance of Precision Immunotherapies, Including TVGN 489 for Vulnerable Individuals Infected with SARS-CoV-2
September 3, 2025

Tevogen Underscores the Importance of Precision Immunotherapies, Including TVGN 489 for Vulnerable Individuals Infected with SARS-CoV-2

Indeterminate GlobeNewswire
Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority
September 3, 2025

Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority

Indeterminate GlobeNewswire
Radiance Biopharma Signs Exclusive License For ‘First In Class’ c-Met/EGFR Targeted Nano Antibody ADC
September 3, 2025

Radiance Biopharma Signs Exclusive License For ‘First In Class’ c-Met/EGFR Targeted Nano Antibody ADC

Indeterminate GlobeNewswire
Aligos Therapeutics Announces Six Preclinical Presentations at the 2025 International HBV Meeting
September 3, 2025

Aligos Therapeutics Announces Six Preclinical Presentations at the 2025 International HBV Meeting

Indeterminate GlobeNewswire
Longeveron® Announces Key Leadership Updates
September 3, 2025

Longeveron® Announces Key Leadership Updates

Indeterminate GlobeNewswire
SAB BIO to Deliver Five Presentations Related to SAB-142 at the 2025 Annual Meeting of the European Association for the Study of Diabetes
September 3, 2025

SAB BIO to Deliver Five Presentations Related to SAB-142 at the 2025 Annual Meeting of the European Association for the Study of Diabetes

Indeterminate GlobeNewswire
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
September 3, 2025

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 3, 2025

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions